Elideth Angulo, MD

Dr. Elideth Angulo, MD, serves as Medical Director at Immunocine, where she exemplifies the organization’s commitment to patient-centered, innovative cancer care rooted in compassion, excellence, and human connection.

Dr. Angulo earned her medical degree from the Universidad Autónoma de Ciudad Juárez in Chihuahua, Mexico, and has spent years practicing across emergency medicine, critical care, and primary care in the Cancún region. This diverse clinical background has shaped her calm, decisive leadership style and deep respect for the complexity of each patient’s medical and personal journey.

Since joining Immunocine, Dr. Angulo has been instrumental in elevating the standard of care by redefining the doctor–patient relationship. She rejects the notion of “quick passes” and instead champions deeper, more meaningful clinical partnerships built on trust, understanding, and long-term investment in the whole person. Her guiding philosophy—that a patient is never defined by their cancer—mirrors the core ethos of Immunocine.

Dr. Angulo has stepped into the role of Medical Director with exceptional dedication and vision, and she leads with empathy, clarity, and unwavering accountability, ensuring that every clinical decision aligns with Immunocine’s mission to treat patients holistically while pushing the boundaries of what cancer care can be. Her ability to unify medical teams around shared values has strengthened both internal culture and patient outcomes.

Committed to continuous growth and innovation, Dr. Angulo actively pursues ongoing education through conferences and professional study. She is also deeply engaged in building strategic relationships within the medical and scientific communities, helping bring world-class talent and ideas to Immunocine.

Dr. Angulo embodies the spirit of Immunocine through her belief in medicine as both a science and a relationship—where compassion, rigor, and purpose come together to transform lives.